Elevated snoRNA biogenesis is essential in breast cancer

Oncogene

Volumn 33, Issue 11, 2014, Pages 1348-1358

  Su, H ^a   Xu, T ^a   Ganapathy, S ^a,b   Shadfan, M ^a   Long, M ^a,b   Huang, T H M ^c   Thompson, I ^a   Yuan, Z M ^a,b  

^a University of Texas Health Science Center   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

breast cancer; fibrillarin; nucleolar stress; p53; snoRNA

Indexed keywords

FIBRILLARIN; PROTEIN P53; SMALL NUCLEOLAR RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOGENESIS; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RNA SYNTHESIS; RNA TRANSLATION; STRESS;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; HUMANS; POLYMERASE CHAIN REACTION; RNA, SMALL NUCLEOLAR;

EID: 84896402896     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.89     Document Type: Article

References (32)

1. Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008; 456: 971-975.
2. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003; 3: 179-192. (Pubitemid 37328870)
3. Kondrashov AV, Kiefmann M, Ebnet K, Khanam T, Muddashetty RS, Brosius J. Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP). J Mol Biol 2005; 353: 88-103. (Pubitemid 41338842)
4. White RJ. RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol 2005; 6: 69-78. (Pubitemid 40064900)
5. Derenzini M, Montanaro L, Trere D. What the nucleolus says to a tumour pathologist. Histopathology 2009; 54: 753-762.
6. Montanaro L, Trere D, Derenzini M. Nucleolus, ribosomes, and cancer. Am J Pathol. 2008; 173: 301-310.
7. Derenzini M, Ploton D. Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 1991; 32: 149-192.
8. Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer? Nat Rev Cancer 2012; 12: 84-88.
9. Mei YP, Liao JP, Shen J, Yu L, Liu BL, Liu L et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 2012; 31: 2794-2804.
10. Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI. Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature 1995; 374: 177-180.
11. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 2000; 97: 3260-3265. (Pubitemid 30183289)
12. Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P et al. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 2001; 20: 1383-1393. (Pubitemid 32233978)
13. Vogt PKPI. 3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med 2001; 7: 482-484.
14. Krastev DB, Slabicki M, Paszkowski-Rogacz M, Hubner NC, Junqueira M, Shevchenko A et al. A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. Nat Cell Biol 2011; 13: 809-818.
15. Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004; 279: 44475-44482. (Pubitemid 39430853)
16. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003; 3: 577-587. (Pubitemid 36808652)
17. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003; 23: 8902-8912. (Pubitemid 37433388)
18. Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004; 24: 7654-7668. (Pubitemid 39121491)
19. Jin A, Itahana K, O'Keefe K, Zhang Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004; 24: 7669-7680. (Pubitemid 39121492)
20. Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16: 369-377.
21. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 1992; 89: 10578-10582.
22. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988; 54: 105-115.
23. Watkins NJ, Lemm I, Ingelfinger D, Schneider C, Hossbach M, Urlaub H et al. Assembly and maturation of the U3 snoRNP in the nucleoplasm in a large dynamic multiprotein complex. Mol Cell 2004; 16: 789-798. (Pubitemid 39586536)
24. Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005; 123: 49-63. (Pubitemid 41414528)
25. Ray PS, Grover R, Das S. Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep 2006; 7: 404-410.
26. Grover R, Ray PS, Das S. Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms. Cell Cycle 2008; 7: 2189-2198. (Pubitemid 352031521)
27. Macias E, Jin A, Deisenroth C, Bhat K, Mao H, Lindstrom MS et al. An ARF-inde-pendent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010; 18: 231-243.
28. Gasco M, Shami S, Crook T. The p53 pathway in breast cancer. Breast Cancer Res 2002; 4: 70-76. (Pubitemid 34248123)
29. Mahata B, Sundqvist A, Xirodimas DP. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Oncogene 2012; 31: 3060-3071.
30. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268. (Pubitemid 36677560)
31. Wang WZ, Cheng J, Luo J, Zhuang SM. Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis. FEBS Lett 2008; 582: 2689-2695.
32. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009; 69: 1135-1142.